Advertisement

Der Nervenarzt

, Volume 85, Issue 1, pp 19–25 | Cite as

REM-Schlaf-Verhaltensstörung als prodromales Stadium von α-Synukleinopathien

Klinik, Epidemiologie, Pathophysiologie, Diagnose und Behandlung
  • W.H. Oertel
  • C. Depboylu
  • M. Krenzer
  • D. Vadasz
  • V. Ries
  • F. Sixel-Döring
  • G. Mayer
Leitthema

Zusammenfassung

Die REM(„rapid eye movement”)-Schlaf-Verhaltensstörung („REM sleep behavior disorder“, RBD) ist definiert als eine Parasomnie, die einerseits durch einen intermittierenden, elektromyographisch nachweisbaren Verlust der REM-Schlaf-assoziierten Atonie und andererseits durch das Auftreten ausgeprägter motorischer Aktivität während des Träumens (in der Regel mit aggressivem Inhalt) charakterisiert ist. Epidemiologische Daten über die Prävalenz von RBD sind wenig aussagekräftig. Die RBD kann idiopathisch oder symptomatisch sein. Für ihre Diagnose ist eine Video-Audio-Polysomnographie essenziell. Pharmakologisch stehen für ihre Behandlung hauptsächlich Clonazepam und Melatonin zur Verfügung. Aktuelle Studien belegen, dass Betroffene mit einer idiopathischen RBD ein auf bis zu 80 % erhöhtes spezifisches Risiko haben, in 10 bis 20 Jahren eine neurodegenerative Erkrankung vom α-Synukleinopathie-Typ (Parkinson-Krankheit, Demenz vom Lewy-Körper-Typ, Multisystematrophie) zu entwickeln. Die vorliegende Arbeit liefert eine kurze Übersicht über die Klinik, Epidemiologie, Pathophysiologie, Diagnose und Therapie der RBD.

Schlüsselwörter

REM-Schlaf-Verhaltensstörung Parkinson-Krankheit Prodromal Alpha-Synukleinopathien Video-Audio-Polysomnographie 

REM sleep behavior disorder as a prodromal stage of α-synucleinopathies

Symptoms, epidemiology, pathophysiology, diagnosis and therapy

Summary

Rapid eye movement (REM) sleep behavior disorder (RBD) is defined as a parasomnia characterized by loss of REM sleep-associated atonia and the presence of motor activity during dreaming typically presenting with an aggressive dream content. Epidemiological data on the prevalence of RBD are insufficient but it can be idiopathic or symptomatic. A video-audio polysomnography is essential for diagnosis. Clonazepam and melatonin are available as pharmaceutical treatment. Recent studies demonstrated that individuals suffering from idiopathic RBD carry a high specific risk (up to 80 %) for developing a neurodegenerative disorder of the α-synucleinopathy type (e.g. Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy) within 10–20 years. The current article provides a short overview of symptoms, epidemiology, pathophysiology, diagnosis and therapy of RBD.

Keywords

REM sleep behavior disorder Parkinson disease Prodromal Alpha-synucleinopathies Video-audio polysomnography 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt. W.H. Oertel, C. Depboylu, M. Krenzer, D. Vadasz, V. Ries, F. Sixel-Döring und G. Mayer: keine Angaben

Literatur

  1. 1.
    Anderson KN, Shneerson JM (2009) Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med 5:235–239PubMedGoogle Scholar
  2. 2.
    Bertrand JA, Bedetti C, Postuma RB et al (2012) Color discrimination deficits in Parkinson’s disease are related to cognitive impairment and white-matter alterations. Mov Disord 27:1781–1788PubMedCrossRefGoogle Scholar
  3. 3.
    Bjørnarå KA, Dietrichs E, Toft M (2013) REM sleep behavior disorder in Parkinson’s disease – is there a gender difference? Parkinsonism Relat Disord 19:120–122PubMedCrossRefGoogle Scholar
  4. 4.
    Bodkin CL, Schenck CH (2009) Rapid eye movement sleep behavior disorder in women: relevance to general and specialty medical practice. J Womens Health (Larchmt) 18:1955–1963CrossRefGoogle Scholar
  5. 5.
    Boeve BF, Silber MH, Ferman TJ (2003) Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 4:281–284PubMedCrossRefGoogle Scholar
  6. 6.
    Boeve BF, Silber MH, Saper CB et al (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770–2788PubMedCrossRefGoogle Scholar
  7. 7.
    Boeve BF (2010) REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 1184:15–54PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Boot BP, Boeve BF, Roberts RO et al (2012) Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann Neurol 71:49–56PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRefGoogle Scholar
  10. 10.
    Cicolin A, Lopiano L, Zibetti M et al (2004) Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Med 5:207–210PubMedCrossRefGoogle Scholar
  11. 11.
    Claassen DO, Josephs KA, Ahlskog JE et al (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494–499PubMedCrossRefGoogle Scholar
  12. 12.
    Dauvilliers Y, Jennum P, Plazzi G (2013) Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy. Sleep Med 14:775–781PubMedCrossRefGoogle Scholar
  13. 13.
    Dauvilliers Y, Postuma RB, Ferini-Strambi L et al (2013) Family history of idiopathic REM behavior disorder: a multicenter case-control study. Neurology 80:2233–2235PubMedCrossRefGoogle Scholar
  14. 14.
    Frauscher B, Iranzo A, Gaig C et al (2012) Normative EMG values during REM sleep for the diagnosis of REM sleep behaviour disorder. Sleep 35:835–847PubMedGoogle Scholar
  15. 15.
    Gagnon JF, Bédard MA, Fantini ML et al (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 59:585–589PubMedCrossRefGoogle Scholar
  16. 16.
    Gagnon JF, Postuma RB, Montplaisir J (2006) Update on the pharmacology of REM sleep behavior disorder. Neurology 67:742–747PubMedCrossRefGoogle Scholar
  17. 17.
    Gagnon JF, Vendette M, Postuma RB et al (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol 66:39–47PubMedCrossRefGoogle Scholar
  18. 18.
    Hernán MA, Takkouche B, Caamaño-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol 52:276–284PubMedCrossRefGoogle Scholar
  19. 19.
    Iranzo A, Aparicio J (2009) A lesson from anatomy: focal brain lesions causing REM sleep behavior disorder. Sleep Med 10:9–12PubMedCrossRefGoogle Scholar
  20. 20.
    Iranzo A, Lomeña F, Stockner H et al (2010) Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol 9:1070–1077PubMedCrossRefGoogle Scholar
  21. 21.
    Iranzo A, Tolosa E, Gelpi E et al (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–445PubMedCrossRefGoogle Scholar
  22. 22.
    Jouvet M, Jeannerod M, Delorme F (1965) Organization of the system responsible for phase activity during paradoxal sleep. C R Seances Soc Biol Fil 159:1599–1604PubMedGoogle Scholar
  23. 23.
    Ju YE, Larson-Prior L, Duntley S (2011) Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med 12:278–283PubMedCrossRefGoogle Scholar
  24. 24.
    Kashihara K, Imamura T, Shinya T (2010) Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson’s disease. Parkinsonism Relat Disord 16:252–255PubMedCrossRefGoogle Scholar
  25. 25.
    Kotagal V, Albin RL, Müller ML et al (2012) Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol 71:560–568PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Krenzer M, Anaclet C, Vetrivelan R et al (2011) Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia. PLoS One 6:e24998PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Kunz D, Mahlberg R (2010) A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 19:591–596PubMedCrossRefGoogle Scholar
  28. 28.
    Lai BC, Marion SA, Teschke K, Tsui JK (2002) Occupational and environmental risk factors for Parkinson’s disease. Parkinsonism Relat Disord 8:297–309PubMedCrossRefGoogle Scholar
  29. 29.
    Luppi PH, Clément O, Sapin E et al (2011) The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Med Rev 15:153–163PubMedCrossRefGoogle Scholar
  30. 30.
    Mahowald MW, Schenck CH, Bornemann MA (2007) Pathophysiologic mechanisms in REM sleep behavior disorder. Curr Neurol Neurosci Rep 7:167–172PubMedCrossRefGoogle Scholar
  31. 31.
    Nomura T, Inoue Y, Högl B et al (2011) Comparison of the clinical features of rapid eye movement sleep behavior disorder in patients with Parkinson’s disease and multiple system atrophy. Psychiatry Clin Neurosci 65:264–271PubMedCrossRefGoogle Scholar
  32. 32.
    Oertel WH, Vadasz D, Ries V et al (2013) Prodromale Marker der Parkinson-Krankheit. Akt Neurol 40:452–461CrossRefGoogle Scholar
  33. 33.
    Ohayon MM, Schenck CH (2010) Violent behavior during sleep: prevalence, comorbidity and consequences. Sleep Med 11:941–946PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Oudiette D, Leu-Semenescu S, Roze E et al (2012) A motor signature of REM sleep behavior disorder. Mov Disord 27:428–431PubMedCrossRefGoogle Scholar
  35. 35.
    Poryazova R, Oberholzer M, Baumann CR, Bassetti CL (2013) REM sleep behavior disorder in Parkinson’sdisease: a questionnaire-based survey. J Clin Sleep Med 9:55–59PubMedGoogle Scholar
  36. 36.
    Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J (2006) Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66:845–851PubMedCrossRefGoogle Scholar
  37. 37.
    Postuma RB, Gagnon JF, Vendette M et al (2008) REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features. J Neurol Neurosurg Psychiatry 79:1117–1121PubMedCrossRefGoogle Scholar
  38. 38.
    Postuma RB, Gagnon JF, Vendette M et al (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72:1296–1300PubMedGoogle Scholar
  39. 39.
    Postuma RB, Gagnon JF, Vendette M, Montplaisir JY (2009) Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease. Brain 132:3298–3307PubMedCrossRefGoogle Scholar
  40. 40.
    Postuma RB, Gagnon JF, Rompré S, Montplaisir JY (2010) Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology 74:239–244PubMedCrossRefGoogle Scholar
  41. 41.
    Postuma RB, Lanfranchi PA, Blais H et al (2010) Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder. Mov Disord 25:2304–2310PubMedCrossRefGoogle Scholar
  42. 42.
    Postuma RB, Gagnon JF, Vendette M et al (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69:811–818PubMedCrossRefGoogle Scholar
  43. 43.
    Postuma RB, Montplaisir J, Lanfranchi P et al (2011) Cardiac autonomic denervation in Parkinson’s disease is linked to REM sleep behavior disorder. Mov Disord 26:1529–1533PubMedCrossRefGoogle Scholar
  44. 44.
    Postuma RB, Montplaisir JY, Pelletier A et al (2012) Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology 79:428–434PubMedCrossRefGoogle Scholar
  45. 45.
    Ringman JM, Simmons JH (2000) Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 55:870–871PubMedCrossRefGoogle Scholar
  46. 46.
    Romenets SR, Gagnon JF, Latreille V et al (2012) Rapid eye movement sleep behavior disorder and subtypes of Parkinson’s disease. Mov Disord 27:996–1003PubMedCrossRefGoogle Scholar
  47. 47.
    Sasai T, Matsuura M, Inoue Y (2013) Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 19:153–157PubMedCrossRefGoogle Scholar
  48. 48.
    Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9:293–308PubMedGoogle Scholar
  49. 49.
    Schenck CH, Mahowald MW (1990) A PSG, neurologic, psychiatric and clinical outcome report on 70 consecutive cases with REM Sleep Behavior Disorder (RBD): sustained clonazepam efficacy in 89.5 % of 57 treated patients. Clev Clin J Med 57:10–24CrossRefGoogle Scholar
  50. 50.
    Schenck CH, Mahowald MW (1996) Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 100:333–337PubMedCrossRefGoogle Scholar
  51. 51.
    Schenck CH, Mahowald MW (2005) Rapid eye movement sleep parasomnias. Neurol Clin 23:1107–1126PubMedCrossRefGoogle Scholar
  52. 52.
    Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81 % of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748PubMedCrossRefGoogle Scholar
  53. 53.
    Schenck CH, Montplaisir JY, Frauscher B et al (2013) Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy – a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med 14:795–806PubMedCrossRefGoogle Scholar
  54. 54.
    Sixel-Döring F, Traumann E, Mollenhauer B, Trenkwalder C (2011) Associated factors for REM sleep behavior disorder in Parkinson’s disease. Neurology 77:1048–1054PubMedCrossRefGoogle Scholar
  55. 55.
    Stiasny-Kolster K, Doerr Y, Moeller JC et al (2005) Combination of ‚idiopathic‘ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126–137PubMedCrossRefGoogle Scholar
  56. 56.
    Stiasny-Kolster K, Mayer G, Schäfer S et al (2007) The REM sleep behavior disorder screening questionnaire – a new diagnostic instrument. Mov Disord 22:2386–2393PubMedCrossRefGoogle Scholar
  57. 57.
    Unger MM, Belke M, Menzler K et al (2010) Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions. Sleep 33:767–773PubMedGoogle Scholar
  58. 58.
    Vetrivelan R, Fuller PM, Tong Q, Lu J (2009) Medullary circuitry regulating rapid eye movement sleep and motor atonia. J Neurosci 29:9361–9369PubMedCentralPubMedCrossRefGoogle Scholar
  59. 59.
    Vyas U, Franco R (2012) REM sleep behavior disorder as an early marker for development of neurodegenerative diseases. BJMP 5:a506Google Scholar
  60. 60.
    Wing YK, Lam SP, Li SX et al (2008) REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J Neurol Neurosurg Psychiatry 79:1415–1416PubMedCrossRefGoogle Scholar
  61. 61.
    Winkelman JW, James L (2004) Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 27:317–321PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • W.H. Oertel
    • 1
  • C. Depboylu
    • 1
  • M. Krenzer
    • 1
  • D. Vadasz
    • 1
  • V. Ries
    • 1
  • F. Sixel-Döring
    • 2
  • G. Mayer
    • 1
    • 3
  1. 1.Klinik für NeurologiePhilipps-UniversitätMarburgDeutschland
  2. 2.Zentrum für Parkinson-Syndrome und BewegungsstörungenParacelsus-Elena-KlinikKasselDeutschland
  3. 3.Klinik für NeurologieHephata-KlinikSchwalmstadt-TreysaDeutschland

Personalised recommendations